Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

5.1K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.1K
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

239
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
239

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Manganese Oxide Nanoparticles for MRI-Based Multimodal Imaging and Theranostics.

Molecules (Basel, Switzerland)·2024
Same author

Machine Learning-Enhanced Quantum Chemistry-Assisted Refinement of the Active Site Structure of Metalloproteins.

Inorganic chemistry·2024
Same author

Interaction of MRI Contrast Agent [Gd(DOTA)]<sup>-</sup> with Lipid Membranes: A Molecular Dynamics Study.

Inorganic chemistry·2024
Same author

Fluorinated Mn(III)/(II)-Porphyrin with Redox-Responsive <sup>1</sup> H and <sup>19</sup> F Relaxation Properties.

Chemistry (Weinheim an der Bergstrasse, Germany)·2023
Same author

MRI Contrast Agents in Glycobiology.

Molecules (Basel, Switzerland)·2022
Same author

High spin Fe(III)-doped nanostructures as T<sub>1</sub> MR imaging probes.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2022

Related Experiment Video

Updated: Jun 29, 2025

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging
07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging

Published on: November 20, 2018

6.5K

Rational Design of Magnetic Nanoparticles as T1-T2 Dual-Mode MRI Contrast Agents.

Carlos F G C Geraldes1,2

  • 1Department of Life Sciences and Coimbra Chemistry Center (CQC-IMS), Faculty of Science and Technology, University of Coimbra, 3004-531 Coimbra, Portugal.

Molecules (Basel, Switzerland)
|March 28, 2024
PubMed
Summary

Magnetic nanoparticles (MNPs) are being optimized as dual-mode contrast agents for magnetic resonance imaging (MRI). These agents can provide both positive (T1) and negative (T2) contrast, enhancing diagnostic capabilities.

Keywords:
bimodal contrast agentmagnetic nanoparticlemagnetic resonance imagingnegative contrastpositive contrast

More Related Videos

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

10.4K
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
11:27

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

9.9K

Related Experiment Videos

Last Updated: Jun 29, 2025

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging
07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging

Published on: November 20, 2018

6.5K
Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

10.4K
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
11:27

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

9.9K

Area of Science:

  • Nanotechnology and Materials Science
  • Biomedical Imaging
  • Radiology

Background:

  • Magnetic nanoparticles (MNPs) are widely researched as contrast agents for magnetic resonance imaging (MRI).
  • MNPs offer tunable magnetic properties, large surface areas, and functionalization capabilities for diagnostic and theranostic applications.
  • Currently, MNPs are used as either positive (T1) or negative (T2) MRI contrast agents.

Purpose of the Study:

  • To review recent advancements in the design and optimization of MNPs as dual-mode T1-T2 MRI contrast agents (DMCAs).
  • To explore strategies for developing DMCAs that can induce both positive and negative contrast in MRI.
  • To discuss the critical role of the r2/r1 relaxivity ratio in achieving dual-mode contrast.

Main Methods:

  • Review of literature focusing on MNPs containing Gd, Mn, Fe, and other lanthanide ions.
  • Analysis of rational design strategies for DMCAs.
  • Discussion of preclinical in vivo applications of designed DMCAs.

Main Results:

  • MNPs can be engineered to function as DMCAs, inducing T1 or T2 contrast by adjusting MRI operational modes.
  • The r2/r1 relaxivity ratio is crucial for DMCAs, ideally falling within the 2-10 range.
  • Two primary design strategies involve using single-contrast material NPs or co-encapsulating T1 and T2 contrast materials.

Conclusions:

  • Dual-mode contrast agents based on magnetic nanoparticles offer enhanced versatility in MRI diagnostics.
  • Rational design approaches enable the development of MNPs with controllable T1 and T2 contrast properties.
  • Further development of DMCAs holds significant promise for advanced MRI-based theranostics.